Balixafortide TFA (POL-6326), a synthetic cyclopeptide derived from polyphemusin, is a novel, potent and orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4, IC 50=10 nM) with anticancer activity. CXCR4 belongs to the transmembrane receptor class of G-coupled protein receptors (GPCR).

纯度：≥98%